Nephron Pharma hands S. Carolina big victory with $313M facility plans

South Carolina politicians have new fodder on the economic-development front to use in their next campaigns for office. Orlando, FL-based Nephron Pharmaceuticals, a maker of generic respiratory drugs, has unveiled plans for a $313 million plant close to Cayce, SC. "This is a big win for our state," South Carolina Gov. Nikki Haley said, as quoted by the Associated Press. Article

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.